During discussions of the clinical microbial sequencing board, clinicians expressed that the results of metagenomic NGS were useful for providing reassurance to the patient, surrogate, or both (e ...

It doesn’t take much imagination to guess how this full genome sequencing could be abused. Last year, a public records lawsuit in New Jersey revealed a worrying new trend of police subpoenaing a ...

The most common drug classes recommended by next-generation sequencing vendors but that clashed with tumor board recommendations included mTOR, PARP, MEK, and PIK3CA inhibitors in off-label settings.

Exome-sequencing analysis and the multidisciplinary UCSF board reviews incorporated thorough details of evolving prenatal phenotypic data, pathological findings in fetuses and infants, and ...

In clinical exome and genome sequencing, there is a potential for the recognition and reporting of incidental or secondary findings unrelated to the indication for ordering the sequencing but of ...

Delve Bio to Present on Metagenomic Next Generation Sequencing (mNGS) at the American Academy of Neurology 2025 Annual Meeting Provided by Business Wire Apr 7, 2025, 11:27:00 AM ...

BOSTON--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data showing that its groundbreaking infectious disease test ...